Institute of Molecular Epidemiology (MELISA), Center of Embryonic Medicine and Maternal Health, Faculty of Medicine, Universidad Católica de la Santísima Concepción, Concepción, Chile ; Faculty of Medicine, University of Chile, Santiago, Chile.
Int J Womens Health. 2012;4:613-23. doi: 10.2147/IJWH.S38063. Epub 2012 Dec 5.
In countries where induced abortion is legally restricted, as in most of Latin America, evaluation of statistics related to induced abortions and abortion-related mortality is challenging. The present article reexamines recent reports estimating the number of induced abortions and abortion-related mortality in Mexico, with special reference to the International Classification of Diseases (ICD). We found significant overestimations of abortion figures in the Federal District of Mexico (up to 10-fold), where elective abortion has been legal since 2007. Significant overestimation of maternal and abortion-related mortality during the last 20 years in the entire Mexican country (up to 35%) was also found. Such overestimations are most likely due to the use of incomplete in-hospital records as well as subjective opinion surveys regarding induced abortion figures, and due to the consideration of causes of death that are unrelated to induced abortion, including flawed denominators of live births. Contrary to previous publications, we found important progress in maternal health, reflected by the decrease in overall maternal mortality (30.6%) from 1990 to 2010. The use of specific ICD codes revealed that the mortality ratio associated with induced abortion decreased 22.9% between 2002 and 2008 (from 1.48 to 1.14 deaths per 100,000 live births). Currently, approximately 98% of maternal deaths in Mexico are related to causes other than induced abortion, such as hemorrhage, hypertension and eclampsia, indirect causes, and other pathological conditions. Therefore, only marginal or null effects would be expected from changes in the legal status of abortion on overall maternal mortality rates. Rather, maternal health in Mexico would greatly benefit from increasing access to emergency and specialized obstetric care. Finally, more reliable methodologies to assess abortion-related deaths are clearly required.
在拉丁美洲的大多数国家,人工流产受到法律限制,因此评估与人工流产和与流产相关的死亡率相关的统计数据具有挑战性。本文重新审视了最近有关墨西哥人工流产和与流产相关的死亡率的报告,特别参考了国际疾病分类(ICD)。我们发现,在联邦区(墨西哥城),人工流产自 2007 年以来合法,其堕胎数字被严重高估(高达 10 倍)。在整个墨西哥,过去 20 年来,孕产妇和与流产相关的死亡率也被严重高估(高达 35%)。这种高估很可能是由于使用了不完全的住院记录,以及关于人工流产数字的主观意见调查,并且还考虑了与人工流产无关的死因,包括出生人数的错误分母。与以前的出版物相反,我们发现了孕产妇健康的重要进展,这反映在 1990 年至 2010 年期间整体孕产妇死亡率下降了 30.6%。使用特定的 ICD 代码表明,2002 年至 2008 年期间,与人工流产相关的死亡率下降了 22.9%(每 10 万例活产中死亡人数从 1.48 人降至 1.14 人)。目前,墨西哥约 98%的孕产妇死亡与人工流产无关,例如出血、高血压和子痫、间接原因和其他病理状况。因此,人工流产法律地位的变化对整体孕产妇死亡率的影响可能微乎其微,甚至没有。相反,墨西哥的孕产妇健康将从增加获得紧急和专业产科护理的机会中大大受益。最后,显然需要更可靠的方法来评估与流产相关的死亡。